Pharmacovigilance Services

End-to-end pharmacovigilance and drug-safety support across the product lifecycle to help organizations manage safety information, regulatory obligations, and patient-risk monitoring.

Overview

Pharmacovigilance is essential for identifying, evaluating, understanding, and preventing adverse effects and other safety-related problems associated with medicinal products.

Mediature GxP Solutions Pvt. Ltd. (MGS) supports Marketing Authorization Holders, pharmaceutical companies, healthcare organizations, and other life-sciences stakeholders with structured pharmacovigilance services covering ICSR processing, safety database activities, literature monitoring, signal management, aggregate reporting, risk management, safety agreements, PSMF support, SOP development, quality compliance, and PV training.

Our approach combines regulatory requirements, medical and scientific review, quality systems, safety-data management, documentation, and lifecycle oversight to help clients establish and maintain effective pharmacovigilance operations.


Our Pharmacovigilance Services Services

Aggregate Reporting

Structured aggregate safety reporting support to help organizations evaluate cumulative safety data, emerging risks, and the evolving benefit-risk profile of medicinal products.

Explore Service →

Risk Management

Structured pharmacovigilance risk-management support to identify, characterize, monitor, minimize, and communicate important product-safety risks throughout the product lifecycle.

Explore Service →

PV SOP Development

Practical, role-based pharmacovigilance SOP development to help organizations standardize safety activities, define responsibilities, and maintain consistent regulatory compliance.

Explore Service →

PV Training

Practical, role-based pharmacovigilance training designed to strengthen safety knowledge, operational consistency, regulatory awareness, and compliance across PV teams and stakeholders.

Explore Service →

SDEA/PVA Management

Structured safety agreement support to clearly define pharmacovigilance responsibilities, safety-data exchange requirements, timelines, and oversight between business partners.

Explore Service →

PSMF Support

Structured Pharmacovigilance System Master File support to help organizations document, maintain, and demonstrate the operation and oversight of their pharmacovigilance system.

Explore Service →

Key Pharmacovigilance Activities We Support

Depending on scope, MGS can support:
  • Adverse event intake
  • Validity assessment
  • Duplicate search
  • Seriousness assessment
  • Expectedness / listedness assessment
  • Causality assessment
  • MedDRA coding
  • Drug coding
  • Narrative preparation
  • Medical review
  • Follow-up activities
  • Expedited reporting
  • Periodic reporting
  • Case reconciliation
  • Literature review
  • Signal tracking
  • Benefit-risk review support
  • Safety database activities
  • PV agreements
  • PSMF maintenance
  • SOP development
  • PV training
  • Quality review
  • Regulatory inspection readiness

 Our Pharmacovigilance Approach

  1. Understand
Review the product portfolio, market status, safety obligations, reporting pathways, existing PV system, and client responsibilities.
  1. Define Responsibilities
Establish clear roles, timelines, escalation pathways, safety-data exchange requirements, and quality controls.
  1. Process & Evaluate
Support collection, processing, medical assessment, review, and documentation of safety information.
  1. Report
Support timely regulatory and partner reporting according to applicable requirements and contractual obligations.
  1. Monitor
Evaluate literature, case trends, emerging safety information, signals, compliance metrics, and safety-system performance.
  1. Maintain & Improve
Support SOP updates, training, CAPA, periodic review, agreements, PSMF maintenance, inspection readiness, and continuous improvement.

Key PV Compliance Considerations

MGS supports clients in addressing areas such as:
  • Case validity
  • Regulatory reporting timelines
  • Data quality
  • Medical review
  • Seriousness
  • Expectedness
  • Causality
  • Coding consistency
  • Duplicate management
  • Follow-up
  • Literature monitoring
  • Signal detection
  • Aggregate reporting
  • Risk management
  • Safety-data exchange
  • Reconciliation
  • Quality oversight
  • Training
  • Documentation
  • Inspection readiness
  • Data integrity
  • Record retention

 Typical PV Deliverables

Depending on the engagement, MGS can provide:
  • Processed ICSRs
  • Case-quality review
  • Medical-review support
  • Regulatory submission files
  • Safety database support
  • Literature-search logs
  • Literature assessment records
  • Signal-tracking documentation
  • Signal assessment reports
  • Aggregate safety reports
  • Risk-management documentation
  • SDEAs / PVAs
  • PSMF documentation
  • PV SOPs and work instructions
  • Training materials
  • Compliance trackers
  • Reconciliation records
  • Quality and inspection-readiness support

What Sets MGS Apart

End-to-End PV Support

MGS can support multiple pharmacovigilance functions within a coordinated operating model.

Quality-Focused Case Management

Our approach emphasizes complete, consistent, medically reviewed, and traceable safety documentation.

Regulatory Awareness

PV activities are structured with consideration of applicable national and international reporting and pharmacovigilance requirements.

Flexible Operating Model

Support can be tailored to individual activities, selected processes, or broader PV-system requirements.

Documentation & Quality Integration

MGS integrates case processing, SOPs, quality systems, agreements, training, and compliance support.

Lifecycle Perspective

Our support can extend from product introduction through routine post-marketing safety surveillance and ongoing system maintenance.

Who We Support

MGS can provide pharmacovigilance support for:
  • Marketing Authorization Holders
  • Pharmaceutical companies
  • Biopharmaceutical companies
  • Generic-drug manufacturers
  • CROs
  • Healthcare organizations
  • Product-license partners
  • Distributors and commercial partners with PV responsibilities
  • Organizations establishing new PV systems
  • Companies expanding or remediating existing PV operations

Protect Patients. Strengthen Safety Systems.

An effective pharmacovigilance system helps organizations identify safety risks early, meet reporting obligations, maintain reliable safety records, and support informed benefit-risk evaluation throughout the product lifecycle. Partner with MGS for practical, quality-focused, and lifecycle-based Pharmacovigilance support.